Bg pattern

OFTACILOX 3 mg/g OPHTHALMIC OINTMENT

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use OFTACILOX 3 mg/g OPHTHALMIC OINTMENT

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

OFTACILOX 3mg/g Ophthalmic Ointment

Ciprofloxacin

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the package leaflet:

  1. What is OFTACILOX ointment and what is it used for
  2. What you need to know before you use OFTACILOX ointment
  3. How to use OFTACILOX ointment
  4. Possible side effects
  5. Storage of OFTACILOX ointment
    1. Contents of the pack and further information

1. What is OFTACILOX ointment and what is it used for

OFTACILOX ointment contains an antibiotic (ciprofloxacin) that belongs to a group of medicines called fluoroquinolones, which acts against certain microorganisms that cause eye infections.

Antibiotics are used to treat bacterial infections and do not work for viral infections.

It is important that you follow the instructions regarding dosage, administration interval, and treatment duration indicated by your doctor.

Do not store or reuse this medicine. If you have any leftover antibiotic after finishing the treatment, return it to the pharmacy for proper disposal. Do not throw away medicines via wastewater or household waste.

This medicine is indicated for the treatment of superficial eye infections and parts surrounding the eye (such as eyelids, etc.).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use OFTACILOX ointment

Do not use OFTACILOX ointment

  • If you are allergic to ciprofloxacin or any of the other components of this medicine (listed in section 6).
  • If you are allergic to other antibiotics of the quinolone group.

Warnings and precautions

Consult your doctor or pharmacist before starting to use OFTACILOX ointment.

  • Use this medicine only in your eye(s).
  • If you experience the first signs of a skin rash or any other hypersensitivity reaction, including hives, itching, or breathing problems, discontinue treatment and consult your doctor immediately. If you suffer a severe allergic reaction, you may need emergency treatment.
  • If your symptoms worsen or come back, consult your doctor. With the use of this medicine, you may become more sensitive to other infections, especially after using it for a long time.
  • If you are an elderly person or are using medicines called corticosteroids used to treat conditions such as pain and inflammation, asthma, or skin problems, then you have a higher risk of tendon problems during treatment with this medicine. If you experience any inflammation or inflammatory condition, discontinue treatment and consult your doctor immediately.
  • If you experience a skin reaction, consult your doctor. Sensitivity to light has been observed with antibiotics. Similar reactions with ciprofloxacin are rare.
  • If during or shortly after using this ointment you feel pain, swelling, or inflammation of the tendons, discontinue treatment and consult your doctor.
  • Use this medicine in children under 1 year of age only if strictly indicated by your doctor.
  • If you are in one of these situations, you may have a higher risk of tendon problems:
  • Advanced age.
  • Steroid treatment.
    • If you use contact lenses:
  • Wearing contact lenses (hard or soft) is not recommended during the treatment of an eye infection.
  • White ocular precipitates (drug residues) have been observed in patients with corneal ulcers and after frequent administration of this medicine, which disappeared after continued application of this medicine. The precipitate does not prevent continued use of this medicine and does not negatively affect the clinical course of the recovery process.

Tell your doctor if you are or have been in the past in one of the above situations.

Using OFTACILOX ointment with other medicines

Tell your doctor or pharmacist that you are using, have recently used, or might use any other medicine.

Using OFTACILOX ointment with food and drinks

It has no influence.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

This medicine is not recommended during pregnancy. Do not use OFTACILOX ointment during pregnancy or breastfeeding, unless your doctor considers it necessary.

If you are breastfeeding, do not use this ointment as it may pass into your breast milk.

Driving and using machines

You may notice that your vision becomes blurry for a moment right after applying the ointment. Do not drive or use machines until these effects have disappeared.

3. How to use OFTACILOX ointment

Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

The recommended dose is:

Follow these instructions unless your doctor has given you different instructions.

Remember to apply your medicine when it is due.

Adultsand children from 1 year

Apply approximately 1 cm of ointment to the eye(s) 3 times a day for the first 2 days, then 2 times a day for 5 more days.

OFTACILOX ointment should only be used via the ophthalmic route, i.e., as an ointment for the eyes.

Your doctor will indicate the duration of your treatment with this medicine.

Recommendations for use:

  • Take the ointment tube.
  • Stand in front of a mirror and wash your hands.
  • In case of conjunctivitis, separate the lower eyelid downward with a clean finger. The ointment should be applied in the pocket formed between the eyelid and the eye.
  • In case of blepharitis, the ointment should be applied to the edge of the eyelid.
  • Place the tip of the tube close to the eye. The mirror can be helpful.
  • Avoid touching the tip of the tube to the eye, eyelid, or surrounding areas.
  • Gently press the tube for the ointment to come out.
  • After applying the ointment, close your eye(s) for a few seconds.
  • Tightly close the tube after use.

If you are using other ophthalmic medicines, wait at least 5 minutes between the administration of this medicine and the other ophthalmic medicines. Ophthalmic ointments should be administered last.

If you use more OFTACILOX ointment than you should, you can eliminate it by washing your eyes with lukewarm water. Do not apply more ointment until the next dose.

In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to use OFTACILOX ointment, apply it as soon as you remember and continue with the next scheduled dose. However, if it is almost time for the next dose, do not apply the missed dose and continue with your regular schedule. Do notapply a double dose to make up for missed doses.

If you stop using OFTACILOX ointment, do not stop using this medicine prematurely, even if the symptoms have disappeared. If you stop using this medicine too early, the symptoms may come back.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, OFTACILOX ointment can cause side effects, although not everybody gets them.

Side effects that may appear after use in the eye:

Common side effects (may affect up to 1 in 10 people)

Eye effects: white deposits on the surface (cornea), discomfort, redness.

General effects: bad taste.

Uncommon side effects (may affect up to 1 in 100 people)

Eye effects: injury or spots on the eye surface (cornea), sensitivity to light, blurred or reduced vision, swelling of the eyelid, eye pain, dry eye, eye swelling, itching in the eye, abnormal sensation in the eye, increased tear production, eye discharge, crust on the eye, eyelid scaling, eyelid redness.

General effects: nausea, headache.

Rare side effects (may affect up to 1 in 1,000 people)

Eye effects: eye injury, corneal disorder, double vision, decreased sensitivity to stimuli in the eye, tired eyes, eye inflammation, eye irritation, hordeolum.

General effects: nasal inflammation, nasal discharge (runny nose), allergy, dizziness, ear pain, diarrhea, abdominal pain, skin inflammation, drug intolerance, abnormal laboratory test.

Frequency not known (cannot be estimated from the available data):

General effects: tendon disorder.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaRAM.es.By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of OFTACILOX ointment

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the tube and carton after EXP. The expiry date is the last day of the month indicated.

Do not refrigerate or freeze. Do not store above 25°C.

To avoid infections, discard the tube 4 weeks after first opening.

Write the date of opening of the tube in the space provided on the carton.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and further information

Composition of OFTACILOX ointment

  • The active substance is ciprofloxacin. Each gram of ointment contains 3 mg of ciprofloxacin (as hydrochloride).
  • The other ingredients are liquid paraffin and white petrolatum.

Appearance of the product and contents of the pack

OFTACILOX ointment is a sterile ointment presented in 3.5 g tubes.

Marketing authorisation holder

NTC s.r.l.,

via Luigi Razza 3,

20124 Milan, Italy

Manufacturer

Siegfried El Masnou, S.A.

C/ Camil Fabra, 58

08320 El Masnou – Barcelona, Spain

Or

S.A. ALCON-COUVREUR N.V.

Rijksweg, 14

Puurs B-2870 Belgium

You can request more information about this medicine by contacting the local representative of the marketing authorisation holder:

NTC Ophthalmics Iberica SL,

Calle Pinar, 5,

28006 Madrid, Spain

Date of last revision of this leaflet: October 2014

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/

Online doctors for OFTACILOX 3 mg/g OPHTHALMIC OINTMENT

Discuss questions about OFTACILOX 3 mg/g OPHTHALMIC OINTMENT, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for OFTACILOX 3 mg/g OPHTHALMIC OINTMENT?
OFTACILOX 3 mg/g OPHTHALMIC OINTMENT requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in OFTACILOX 3 mg/g OPHTHALMIC OINTMENT?
The active ingredient in OFTACILOX 3 mg/g OPHTHALMIC OINTMENT is ciprofloxacin. This information helps identify medicines with the same composition but different brand names.
How much does OFTACILOX 3 mg/g OPHTHALMIC OINTMENT cost in pharmacies?
The average pharmacy price for OFTACILOX 3 mg/g OPHTHALMIC OINTMENT is around 3.25 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures OFTACILOX 3 mg/g OPHTHALMIC OINTMENT?
OFTACILOX 3 mg/g OPHTHALMIC OINTMENT is manufactured by Ntc S.R.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of OFTACILOX 3 mg/g OPHTHALMIC OINTMENT online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether OFTACILOX 3 mg/g OPHTHALMIC OINTMENT is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to OFTACILOX 3 mg/g OPHTHALMIC OINTMENT?
Other medicines with the same active substance (ciprofloxacin) include CETRAFLUX 3 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS, OFTACILOX 3 mg/ml EYE DROPS SOLUTION, ABIMOX 5 mg/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media